Asia-Pacific Clinical Trial Imaging Market – Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET: DBMR MARKET POSITION GRID

2.8 DBMR VENDOR SHARE ANALYSIS

2.9 MULTIVARIATE MODELING

2.10 PRODUCTS LIFELINE CURVE

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING R&D EXPENDITURE

3.1.2 INCREASING NUMBER OF CONTRACT RESEARCH ORGANIZATION

3.1.3 INCREASING PREVALENCE OF CHRONIC DISEASES

3.1.4 GROWTH IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES

3.2 RESTRAINTS

3.2.1 HIGH RISK RADIATION CAUSING DISEASES

3.2.2 HIGH IMPLEMENTATION COST OF IMAGING SYSTEMS

3.3 OPPORTUNITIES

3.3.1 STRATEGIC INITIATIVES FOR BUSINESS EXPANSION

3.3.2 DEVELOPMENT OF INNOVATIVE IMAGING MODALITIES AND CONTRAST AGENTS

3.3.3 EMERGING ECONOMIES

3.4 CHALLENGES

3.4.1 STRICT REGULATORY POLICIES

3.4.2 COST OF CLINICAL TRIALS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 ASIA-PACIFIC CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES

6.1 OVERVIEW

6.2 SERVICES

6.2.1 OPERATIONAL IMAGING SERVICES

6.2.2 READ ANALYSIS SERVICES

6.2.3 TRIAL DESIGN CONSULTING SERVICES

6.2.4 SYSTEM AND TECHNICAL SUPPORT SERVICES

6.3 SOFTWARE

7 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 ONCOLOGY

7.2.1 ECHOCARDIOGRAPHY

7.2.2 MAGNETIC RESONANCE IMAGING

7.2.3 COMPUTED TOMOGRAPHY

7.2.4 POSITRON EMISSION TOMOGRAPHY

7.2.5 NUCLEAR MEDICINE

7.2.6 X-RAY

7.2.7 ULTRASOUND

7.2.8 OPTICAL COHERENCE TOMOGRAPHY

7.2.9 OTHERS

7.3 NEUROLOGY

7.3.1 COMPUTED TOMOGRAPHY

7.3.2 MAGNETIC RESONANCE IMAGING

7.3.3 POSITRON EMISSION TOMOGRAPHY

7.3.4 NUCLEAR MEDICINE

7.3.5 X-RAY

7.3.6 ULTRASOUND

7.3.7 OPTICAL COHERENCE TOMOGRAPHY

7.3.8 OTHERS

7.4 ENDOCRINOLOGY

7.4.1 COMPUTED TOMOGRAPHY

7.4.2 MAGNETIC RESONANCE IMAGING

7.4.3 POSITRON EMISSION TOMOGRAPHY

7.4.4 NUCLEAR MEDICINE

7.4.5 X-RAY

7.4.6 ULTRASOUND

7.4.7 OPTICAL COHERENCE TOMOGRAPHY

7.4.8 OTHERS

7.5 CARDIOLOGY

7.5.1 X-RAY

7.5.2 ULTRASOUND

7.5.3 COMPUTED TOMOGRAPHY

7.5.4 MAGNETIC RESONANCE IMAGING

7.5.5 NUCLEAR MEDICINE

7.5.6 POSITRON EMISSION TOMOGRAPHY

7.5.7 OPTICAL COHERENCE TOMOGRAPHY

7.5.8 ECHOCARDIOGRAPHY

7.5.9 OTHERS

7.6 DERMATOLOGY

7.6.1 ULTRASOUND

7.6.2 X-RAY

7.6.3 MAGNETIC RESONANCE IMAGING

7.6.4 COMPUTED TOMOGRAPHY

7.6.5 OPTICAL COHERENCE TOMOGRAPHY

7.6.6 POSITRON EMISSION TOMOGRAPHY

7.6.7 NUCLEAR MEDICINE

7.6.8 OTHERS

7.7 HEMATOLOGY

7.7.1 ULTRASOUND

7.7.2 COMPUTED TOMOGRAPHY

7.7.3 MAGNETIC RESONANCE IMAGING

7.7.4 X-RAY

7.7.5 POSITRON EMISSION TOMOGRAPHY

7.7.6 NUCLEAR MEDICINE

7.7.7 OPTICAL COHERENCE TOMOGRAPHY

7.7.8 ECHOCARDIOGRAPHY

7.7.9 OTHERS

8 ASIA-PACIFIC CLINICAL TRIAL IMAGINGMARKET, BY MODALITY

8.1 OVERVIEW

8.2 COMPUTED TOMOGRAPHY

8.3 MAGNETIC RESONANCE IMAGING

8.4 ULTRASOUND

8.5 POSITRON EMISSION TOMOGRAPHY

8.6 X-RAY

8.7 ECHOCARDIOGRAPHY

8.8 NUCLEAR MEDICINE

8.9 OPTICAL COHERENCE TOMOGRAPHY

8.10 OTHERS

9 ASIA-PACIFIC CLINICAL TRIAL IMAGINGMARKET, BY END USER

9.1 OVERVIEW

9.2 CONTRACT RESEARCH ORGANIZATION

9.3 MEDICAL DEVICE MANUFACTURERS

9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

9.5 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES

10 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR

10.1 OVERVIEW

10.2 DIRECT SALES

10.3 TENDERS SALES

11 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY GEOGRAPHY

11.1 ASIA-PACIFIC

11.1.1 CHINA

11.1.2 JAPAN

11.1.3 SOUTH KOREA

11.1.4 INDIA

11.1.5 AUSTRALIA

11.1.6 SINGAPORE

11.1.7 THAILAND

11.1.8 MALAYSIA

11.1.9 INDONESIA

11.1.10 PHILIPPINES

11.1.11 REST OF ASIA-PACIFIC

12 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 COMPANY PROFILE

13.1 NAVITAS LIFE SCIENCES

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 SERVICE PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.2 RESONANCE HEALTH

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 SERVICE PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.3 BIOTELEMETRY, INC.

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 SERVICEPORTFOLIO

13.3.5 RECENT DEVELOPMENTS

13.4 IXICO PLC

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 SERVICE PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.5 ICON PLC

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 SERVICE PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.6 IMAGE CORE LAB

13.6.1 COMPANY SNAPSHOT

13.6.2 SERVICE PORTFOLIO

13.6.3 RECENT DEVELOPMENT

13.7 ANAGRAM 4 CLINICAL TRIALS

13.7.1 COMPANY SNAPSHOT

13.7.2 SERVICE PORTFOLIO

13.7.3 RECENT DEVELOPMENT

13.8 BIOCLINICA

13.8.1 COMPANY SNAPSHOT

13.8.2 SERVICE PORTFOLIO

13.8.3 RECENT DEVELOPMENTS

13.9 CARDIOVASCULAR IMAGING TECHNOLOGIES

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENT

13.10 ERT CLINICAL

13.10.1 COMPANY SNAPSHOT

13.10.2 SERVICE PORTFOLIO

13.10.3 RECENT DEVELOPMENTS

13.11 INTRINSIC IMAGING

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 SERVICE PORTFOLIO

13.11.4 RECENT DEVELOPMENTS

13.12 LYSCAUT MEDICAL IMAGING COMPANY

13.12.1 COMPANY SNAPSHOT

13.12.2 SERVICE PORTFOLIO

13.12.3 RECENT DEVELOPMENT

13.13 PAREXEL INTERNATIONAL CORPORATION

13.13.1 COMPANY SNAPSHOT

13.13.2 SERVICE PORTFOLIO

13.13.3 RECENT DEVELOPMENTS

13.14 PERSPECTUM DIAGNOSTICS

13.14.1 COMPANY SNAPSHOT

13.14.2 PRODUCT PORTFOLIO

13.14.3 SERVICE PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 QUOTIENT SCIENCES

13.15.1 COMPANY SNAPSHOT

13.15.2 SERVICE PORTFOLIO

13.15.3 RECENT DEVELOPMENTS

13.16 RADIANT SAGE LLC

13.16.1 COMPANY SNAPSHOT

13.16.2 PRODUCT PORTFOLIO

13.16.3 SERVICE PORTFOLIO

13.16.4 RECENT DEVELOPMENTS

13.17 WORLDCARE CLINICAL

13.17.1 COMPANY SNAPSHOT

13.17.2 SERVICE PORTFOLIO

13.17.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

UU

TABLE 1 COST OF CLINICAL TRIAL PHASE 2 AND PHASE 3

TABLE 2 HUGE R&D COST IN THE U.S. FOR DIFFERENT PHASES

TABLE 3 ASIA-PACIFIC CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES, 2017-2026 (USD MILLION)

TABLE 4 ASIA-PACIFIC SERVICES IN CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 5 ASIA-PACIFIC SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 6 ASIA-PACIFIC SOFTWARE CLINICAL TRIAL IMAGING MARKET,BY REGION, 2017-2026 (USD MILLION)

TABLE 7 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 8 ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 ASIA-PACIFIC ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 10 ASIA-PACIFIC NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 ASIA-PACIFIC NEUROLOGYI N CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 12 ASIA-PACIFIC ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 ASIA-PACIFIC ENDOCRINOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 14 ASIA-PACIFIC CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 ASIA-PACIFIC CARDIOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 16 ASIA-PACIFIC DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 ASIA-PACIFIC DERMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 18 ASIA-PACIFIC HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 ASIA-PACIFIC HEMATOLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 20 ASIA-PACIFIC CLINICAL TRIAL IMAGINGMARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 21 ASIA-PACIFIC COMPUTED TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 ASIA-PACIFIC MAGNETIC RESONANCE IMAGING IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 ASIA-PACIFIC ULTRASOUND IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 ASIA-PACIFIC X-RAY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 ASIA-PACIFIC ECHOCARDIOGRAPHY IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 ASIA-PACIFIC NUCLEAR MEDICINE IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 ASIA-PACIFIC OPTICAL COHERENCE TOMOGRAPHYIN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 ASIA-PACIFIC OTHERS SEGMENTS IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 ASIA-PACIFIC CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 31 ASIA-PACIFIC BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 ASIA-PACIFIC MEDICAL DEVICE MANUFACTURERS COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 ASIA-PACIFIC ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES IN CLINICAL TRIAL IMAGINGMARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 ASIA-PACIFIC CLINICAL TRIAL IMAGINGMARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 36 ASIA-PACIFIC DIRECT SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 37 ASIA-PACIFIC TENDERS SALES IN CLINICAL TRIAL IMAGING MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET,BYCOUNTRY, 2017-2026 (USD MILLION)

TABLE 39 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 40 ASIA-PACIFIC SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 41 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 42 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 43 ASIA-PACIFIC ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 44 ASIA-PACIFIC NEUROLOGY CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 45 ASIA-PACIFIC ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION,2017-2026 (USD MILLION)

TABLE 46 ASIA-PACIFIC CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 47 ASIA-PACIFIC DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 48 ASIA-PACIFIC HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 49 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 50 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 51 CHINA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 52 CHINA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 53 CHINA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 54 CHINA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 55 CHINA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 56 CHINA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 57 CHINA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 58 CHINA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 59 CHINA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 60 CHINA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 61 CHINA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 62 CHINA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 63 JAPAN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 64 JAPAN SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 65 JAPAN CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 66 JAPAN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 67 JAPAN ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 68 JAPAN NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 69 JAPAN ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 70 JAPAN CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 71 JAPAN DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 72 JAPAN HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 73 JAPAN CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 74 JAPAN CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 75 SOUTH KOREA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 76 SOUTH KOREA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 77 SOUTH KOREA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 78 SOUTH KOREA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 79 SOUTH KOREA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 80 SOUTH KOREA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 81 SOUTH KOREA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 82 SOUTH KOREA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 83 SOUTH KOREA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 84 SOUTH KOREA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 85 SOUTH KOREA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 86 SOUTH KOREA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 87 INDIA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 88 INDIA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 89 INDIA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 90 INDIA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 91 INDIA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 92 INDIA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 93 INDIA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 94 INDIA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 95 INDIA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 96 INDIA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 97 INDIA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 98 INDIA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 99 AUSTRALIA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 100 AUSTRALIA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 101 AUSTRALIA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 102 AUSTRALIA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 103 AUSTRALIA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 104 AUSTRALIA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 105 AUSTRALIA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 106 AUSTRALIA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 107 AUSTRALIA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 108 AUSTRALIA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 109 AUSTRALIA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 110 AUSTRALIA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 111 SINGAPORE CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 112 SINGAPORE SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 113 SINGAPORE CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 114 SINGAPORE CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 115 SINGAPORE ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 116 SINGAPORE NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 117 SINGAPORE ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 118 SINGAPORE CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 119 SINGAPORE DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 120 SINGAPORE HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 121 SINGAPORE CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 122 SINGAPORE CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 123 THAILAND CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 124 THAILAND SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 125 THAILAND CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 126 THAILAND CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 127 THAILAND ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 128 THAILAND NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 129 THAILAND ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 130 THAILAND CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 131 THAILAND DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 132 THAILAND HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 133 THAILAND CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 134 THAILAND CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 135 MALAYSIA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 136 MALAYSIA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 137 MALAYSIA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 138 MALAYSIA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 139 MALAYSIA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 140 MALAYSIA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 141 MALAYSIA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 142 MALAYSIA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 143 MALAYSIA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 144 MALAYSIA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 145 MALAYSIA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 146 MALAYSIA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 147 INDONESIA CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 148 INDONESIA SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 149 INDONESIA CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 150 INDONESIA CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 151 INDONESIA ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 152 INDONESIA NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 153 INDONESIA ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 154 INDONESIA CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 155 INDONESIA DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 156 INDONESIA HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 157 INDONESIA CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 158 INDONESIA CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 159 PHILIPPINES CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 160 PHILIPPINES SERVICES IN CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)

TABLE 161 PHILIPPINES CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2017-2026 (USD MILLION)

TABLE 162 PHILIPPINES CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 163 PHILIPPINES ONCOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 164 PHILIPPINES NEUROLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 165 PHILIPPINES ENDOCRINOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 166 PHILIPPINES CARDIOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 167 PHILIPPINES DERMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 168 PHILIPPINES HEMATOLOGY IN CLINICAL TRIAL IMAGING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 169 PHILIPPINES CLINICAL TRIAL IMAGING MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 170 PHILIPPINES CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR, 2017-2026 (USD MILLION)

TABLE 171 REST OF ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)